Table of contents

Volume 94, Issue 1
Published online 11 January 2006 (1-178)

Top

Minireviews

Adrenomedullin and tumour angiogenesis FREE

L L Nikitenko, S B Fox, S Kehoe, M C P Rees and R Bicknell

Br J Cancer 94: 1-7; advance online publication, October 25, 2005; doi:10.1038/sj.bjc.6602832

The measurement and therapeutic implications of circulating tumour cells in breast cancer FREE

J B Smerage and D F Hayes

Br J Cancer 94: 8-12; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602871

A twist for survival and cancer progression FREE

A Puisieux, S Valsesia-Wittmann and S Ansieau

Br J Cancer 94: 13-17; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602876

Top

Clinical Studies

Time and chemotherapy treatment trends in the treatment of elderly patients (age greater than or equal to70 years) with small cell lung cancer FREE

T Yau, S Ashley, S Popat, A Norton, A Matakidou, J Coward and M E R O'Brien

Br J Cancer 94: 18-21; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602888

Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994 FREE

C A Stiller, S J Passmore, M E Kroll, P A Brownbill, J C Wallis and A W Craft

Br J Cancer 94: 22-29; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602885

Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom FREE

J E Lester, D Dodwell, J M Horsman, S Mori and R E Coleman

Br J Cancer 94: 30-35; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602892

Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study FREE

P C Allgood and M O Bachmann

Br J Cancer 94: 36-42; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602894

Factors associated with emotional and behavioural problems among school age children of breast cancer patients FREE

M Watson, I St. James-Roberts, S Ashley, C Tilney, B Brougham, L Edwards, C Baldus and G Romer

Br J Cancer 94: 43-50; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602887

Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate? FREE

T Powles, P Savage, D Short, A Young, C Pappin and M J Seckl

Br J Cancer 94: 51-54; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602899

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer FREE

A R Clamp, J Mäenpää, D Cruickshank, J Ledermann, P M Wilkinson, R Welch, S Chan, P Vasey, B Sorbe, A Hindley and G C Jayson for the Scottish Gynaecological Cancer Trials Group

Br J Cancer 94: 55-61; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602910

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer FREE

P A Vasey, R Atkinson, R Osborne, D Parkin, R Symonds, J Paul, L Lewsley, R Coleman, N S Reed, S Kaye and G J S Rustin

Br J Cancer 94: 62-68; doi:10.1038/sj.bjc.6602909

'A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer' FREE

J Bennouna, H Perrier, B Paillot, F Priou, J H Jacob, M Hebbar, S Bordenave, J F Seitz, F Cvitkovic, E Dorval, K Malek, D Tonelli and J Y Douillard

Br J Cancer 94: 69-73; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602913

Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial FREE

C Rothermundt, R Hubner, T Ahmad, I Gibbens, C Keyzor, T Habeshaw, S Kaye and M Gore

Br J Cancer 94: 74-78; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602879

A phase I and pharmacokinetic study of novel taxane BMS-188797 and cisplatin in patients with advanced solid tumours FREE

A du Bois, B Jung, A Loehr, T Schaller-Kranz, M Cohen and N Frickhofen

Br J Cancer 94: 79-84; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602886

Top

Translational Therapeutics

Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies FREE

I Laux, A Jain, S Singh and D B Agus

Br J Cancer 94: 85-92; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602875

Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells FREE

J C Panetta, W E Evans and M H Cheok

Br J Cancer 94: 93-100; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602893

Macrophages promote angiogenesis in human breast tumour spheroids in vivo  FREE

L Bingle, C E Lewis, K P Corke, M W R Reed and N J Brown

Br J Cancer 94: 101-107; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602901

Top

Molecular Diagnostics

Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma FREE

D Xie, Y X Zeng, H J Wang, J M Wen, Y Tao, J S T Sham and X Y Guan

Br J Cancer 94: 108-114; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602904

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix FREE

P Kabuubi, J A Loncaster, S E Davidson, R D Hunter, C Kobylecki, I J Stratford and C M L West

Br J Cancer 94: 115-120; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602882

The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model FREE

G Atkin, F M Daley, S Bourne, R Glynne-Jones, J Northover and G D Wilson

Br J Cancer 94: 121-127; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602905

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers FREE

P Went, M Vasei, L Bubendorf, L Terracciano, L Tornillo, U Riede, J Kononen, R Simon, G Sauter and P A Baeuerle

Br J Cancer 94: 128-135; doi:10.1038/sj.bjc.6602924

Top

Epidemiology

Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas FREE

M Lindblad, L A García Rodríguez, E Chandanos and J Lagergren

Br J Cancer 94: 136-141; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602906

Birth outcome in women with breast cancer FREE

V Langagergaard, M Gislum, M V Skriver, B Nørgård, T L Lash, K J Rothman and H T Sørensen

Br J Cancer 94: 142-146; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602878

Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients FREE

J Anttinen, H Kautiainen and T Kuopio

Br J Cancer 94: 147-151; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602895

Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996 FREE

G Menvielle, A Leclerc, J-F Chastang and D Luce for the EDISC group

Br J Cancer 94: 152-155; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602907

Adiponectin in relation to childhood myeloblastic leukaemia FREE

E Petridou, C S Mantzoros, N Dessypris, S K Dikalioti and D Trichopoulos the Childhood Hematology Oncology Group

Br J Cancer 94: 156-160; doi:10.1038/sj.bjc.6602896

Magnetic field exposure and long-term survival among children with leukaemia FREE

D E Foliart, B H Pollock, G Mezei, R Iriye, J M Silva, K L Ebi, L Kheifets, M P Link and R Kavet

Br J Cancer 94: 161-164; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602916

Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer FREE

M Mommers, L J Schouten, R A Goldbohm and P A van den Brandt

Br J Cancer 94: 165-170; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602890

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands FREE

S Bulk, J Berkhof, N W J Bulkmans, G D Zielinski, L Rozendaal, F J van Kemenade, P J F Snijders and C J L M Meijer

Br J Cancer 94: 171-175; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602915

Top

Letter to the Editor

Does a truncated form of the transcription factor Ets1 exist in breast cancer cells? FREE

J Dittmer

Br J Cancer 94: 176-177; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602903

Top

Book Review

Nerve Blocks in Palliative Care FREE

A P Baranowski

Br J Cancer 94: 178; doi:10.1038/sj.bjc.6602884

The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.

Extra navigation

ADVERTISEMENT

naturejobs